Lord, Abbett & Co
REPL icon

Lord, Abbett & Co’s Replimune Group REPL Stock Holding History

Lord, Abbett & Co’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-184,419
Closed -$3.16M – 574
2023
Q3 		$3.16M Sell
184,419
-854,087
-82% -$16.8M 0.01% 504
2023
Q2 		$24.1M Buy
+1,038,506
New +$20.3M 0.08% 310

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lord, Abbett & Co's REPL Position: Q4 2023 in Review

Lord, Abbett & Co sold out of Replimune Group (REPL) in Q4 2023, closing a stake of 184,419 shares — an estimated $3.16M sold.

Lord, Abbett & Co first reported a position in REPL in Q2 2023 and held it in 2 quarters. The position peaked at $24.1M in Q2 2023. 140 funds tracked by Wall St. Rank hold REPL as of Q4 2023.

  • Lord, Abbett & Co reported no remaining Replimune Group position as of Q4 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 184,419 Replimune Group shares in Q4 2023, an estimated $3.16M.
  • Lord, Abbett & Co first reported a position in Replimune Group in Q2 2023 and held it in 2 quarters.
  • Lord, Abbett & Co's Replimune Group position peaked at $24.1M in Q2 2023.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q4 2023.

Based on Lord, Abbett & Co's 13F filing for Q4 2023, filed 12 Feb 2024.